uniQure N.V. (NASDAQ: QURE) Stock Information | RedChip

uniQure N.V. (NASDAQ: QURE)


$9.13
+0.4100 ( +4.70% ) 4.0M

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

Market Data


Open


$9.13

Previous close


$8.72

Volume


4.0M

Market cap


$442.29M

Day range


$8.54 - $9.75

52 week range


$3.73 - $11.35

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Jun 17, 2024
4 Insider transactions 1 Jun 17, 2024
8-k 8K-related 15 Jun 03, 2024
8-k 8K-related 15 May 07, 2024
10-q Quarterly Reports 62 May 07, 2024
ars Annual reports 1 May 01, 2024
def Proxies and info statements 20 Apr 24, 2024
8-k 8K-related 13 Apr 12, 2024
pre Proxies and info statements 21 Apr 12, 2024
4 Insider transactions 1 Mar 05, 2024

Latest News